| ViraEpi737 | Epstein barr virus (EBV) | Wp | NA | 14381 | 14381 | No methylation | 0% | Wp-restricted cell line | Ava-BL c.1 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi738 | Epstein barr virus (EBV) | Wp | NA | 14391 | 14391 | No methylation | 0% | Wp-restricted cell line | Ava-BL c.1 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi739 | Epstein barr virus (EBV) | Wp | NA | 14445 | 14445 | Hyper | 58.33% | Wp-restricted cell line | Ava-BL c.1 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi740 | Epstein barr virus (EBV) | Wp | NA | 14462 | 14462 | Hyper | 41.66% | Wp-restricted cell line | Ava-BL c.1 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi741 | Epstein barr virus (EBV) | Wp | NA | 13956 | 13956 | Intermediate | 57.14% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi742 | Epstein barr virus (EBV) | Wp | NA | 13976 | 13976 | Hyper | 64.28% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi743 | Epstein barr virus (EBV) | Wp | NA | 14015 | 14015 | Hypo | 28.57% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi744 | Epstein barr virus (EBV) | Wp | NA | 14077 | 14077 | Hyper | 92.85% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi745 | Epstein barr virus (EBV) | Wp | NA | 14085 | 14085 | Hyper | 92.85% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi746 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Hyper | 92.85% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi747 | Epstein barr virus (EBV) | Wp | NA | 14103 | 14103 | Hyper | 92.85% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi748 | Epstein barr virus (EBV) | Wp | NA | 14105 | 14105 | Hyper | 92.85% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi749 | Epstein barr virus (EBV) | Wp | NA | 14115 | 14115 | Hyper | 85.71% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi750 | Epstein barr virus (EBV) | Wp | NA | 14143 | 14143 | Intermediate | 50% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi751 | Epstein barr virus (EBV) | Wp | NA | 14161 | 14161 | Hyper | 71.42% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi752 | Epstein barr virus (EBV) | Wp | NA | 14259 | 14259 | Hyper | 71.42% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi753 | Epstein barr virus (EBV) | Wp | NA | 14261 | 14261 | Hyper | 64.28% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi754 | Epstein barr virus (EBV) | Wp | NA | 14288 | 14288 | Hyper | 71.42% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi755 | Epstein barr virus (EBV) | Wp | NA | 14290 | 14290 | Hyper | 71.42% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 |